NSABP B-47/NRG Oncology Phase III Randomized Trial Comparing Adjuvant Chemotherapy With or Without Trastuzumab in High-Risk Invasive Breast Cancer Negative for HER2 by FISH and With IHC 1+ or 2 - Fehrenbacher, L; Cecchini, RS; Geyer, CE (Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2020)
et al.